Brinker Capital Investments, LLC - EXAGEN INC ownership

EXAGEN INC's ticker is XGN and the CUSIP is 30068X103. A total of 54 filers reported holding EXAGEN INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Brinker Capital Investments, LLC ownership history of EXAGEN INC
ValueSharesWeighting
Q3 2022$269,000
-48.3%
99,115
+9.4%
0.01%
-40.0%
Q2 2022$520,000
-30.6%
90,596
-2.8%
0.01%
-16.7%
Q1 2022$749,000
-9.8%
93,218
+30.6%
0.01%0.0%
Q4 2021$830,000
-53.9%
71,393
-40.6%
0.01%
-58.6%
Q3 2021$1,802,0000.0%120,2390.0%0.03%
+20.8%
Q2 2021$1,802,000120,2390.02%
Other shareholders
EXAGEN INC shareholders Q3 2021
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,203,491$2,912,4480.97%
PERKINS CAPITAL MANAGEMENT INC 263,905$6390.63%
COWEN AND COMPANY, LLC 842,376$2,063,8210.14%
Penbrook Management LLC 73,410$177,6520.13%
RTW INVESTMENTS, LP 1,492,432$3,611,6850.08%
Nantahala Capital Management 106,769$258,3810.02%
WASATCH ADVISORS LP 856,273$2,097,8690.01%
SILVERCREST ASSET MANAGEMENT GROUP LLC 544,877$1,318,6020.01%
First Bank & Trust 14,375$34,7880.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 40,800$99,9600.00%
View complete list of EXAGEN INC shareholders